197 related articles for article (PubMed ID: 23605155)
21. Breast and Cervical Cancer Screening Prevalence and Associated Factors among Women in the South African General Population.
Phaswana-Mafuya N; Peltzer K
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1465-1470. PubMed ID: 29936716
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for nonadherence with Pap testing in HIV-infected women.
Baranoski AS; Horsburgh CR; Cupples LA; Aschengrau A; Stier EA
J Womens Health (Larchmt); 2011 Nov; 20(11):1635-43. PubMed ID: 21879883
[TBL] [Abstract][Full Text] [Related]
23. Study protocol for the most effective recall method in a cervical cancer screening program in Klang, Malaysia.
Abdul Rashid RM; Dahlui M
Asian Pac J Cancer Prev; 2013; 14(10):5867-70. PubMed ID: 24289591
[TBL] [Abstract][Full Text] [Related]
24. Cervical cancer screening after 50: near extinction?
Abdullah NN; Daud S; Al-Kubaisy W; Saari IS; Saad SR
Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():136-140. PubMed ID: 27693934
[TBL] [Abstract][Full Text] [Related]
25. Socioeconomic determinants of cervical cancer screening in Latin America.
Soneji S; Fukui N
Rev Panam Salud Publica; 2013 Mar; 33(3):174-82. PubMed ID: 23698136
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of cervical cancer screening of HIV-infected women in the United States.
Oster AM; Sullivan PS; Blair JM
J Acquir Immune Defic Syndr; 2009 Aug; 51(4):430-6. PubMed ID: 19474756
[TBL] [Abstract][Full Text] [Related]
27. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
Açikgöz A; Ergör G
Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
[TBL] [Abstract][Full Text] [Related]
28. Predictors of early rescreening in the National Cervical Screening Program, Australia.
Mitchell H; Hocking J
Aust N Z J Public Health; 2001 Aug; 25(4):334-8. PubMed ID: 11529614
[TBL] [Abstract][Full Text] [Related]
29. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
[TBL] [Abstract][Full Text] [Related]
30. Trends Over Time in Pap and Pap-HPV Cotesting for Cervical Cancer Screening.
MacLaughlin KL; Jacobson RM; Radecki Breitkopf C; Wilson PM; Jacobson DJ; Fan C; St Sauver JL; Rutten LJF
J Womens Health (Larchmt); 2019 Feb; 28(2):244-249. PubMed ID: 30614380
[TBL] [Abstract][Full Text] [Related]
31. Cervical cancer screening among Lebanese women.
Bou-Orm IR; Sakr RE; Adib SM
Rev Epidemiol Sante Publique; 2018 Feb; 66(1):1-6. PubMed ID: 29249573
[TBL] [Abstract][Full Text] [Related]
32. Differences in Breast and Cervical Cancer Screening Rates in Jordan among Women from Different Socioeconomic Strata: Analysis of the 2012 Population-Based Household Survey.
Al Rifai R; Nakamura K
Asian Pac J Cancer Prev; 2015; 16(15):6697-704. PubMed ID: 26434897
[TBL] [Abstract][Full Text] [Related]
33. Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study.
Maura G; Chaignot C; Weill A; Alla F; Heard I
Eur J Cancer Prev; 2018 Sep; 27(5):479-485. PubMed ID: 28368950
[TBL] [Abstract][Full Text] [Related]
34. Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient.
Guo F; Hirth JM; Berenson AB
J Womens Health (Larchmt); 2017 Oct; 26(10):1114-1122. PubMed ID: 28841084
[TBL] [Abstract][Full Text] [Related]
35. Cervical screening uptake and its predictors among rural women in Malaysia.
Gan DE; Dahlui M
Singapore Med J; 2013 Mar; 54(3):163-8. PubMed ID: 23546031
[TBL] [Abstract][Full Text] [Related]
36. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Lerdlukanavonge P; Koonchote S
Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
[TBL] [Abstract][Full Text] [Related]
37. Barriers and Facilitators of Pap Testing for Women Living With HIV: A Focus Group Study.
Jin S; Cudjoe J; Peay A; Baker D; Kunkel J; Sharps P; Han HR
J Assoc Nurses AIDS Care; 2020; 31(2):190-196. PubMed ID: 31567730
[No Abstract] [Full Text] [Related]
38. The frequency of Pap smear screening in the United States.
Sirovich BE; Welch HG
J Gen Intern Med; 2004 Mar; 19(3):243-50. PubMed ID: 15009779
[TBL] [Abstract][Full Text] [Related]
39. High prevalence of abnormal Pap smears among young women co-infected with HIV in rural South Africa - implications for cervical cancer screening policies in high HIV prevalence populations.
Gaym A; Mashego M; Kharsany AB; Walldorf J; Frohlich J; Karim QA
S Afr Med J; 2007 Feb; 97(2):120-3. PubMed ID: 17404673
[TBL] [Abstract][Full Text] [Related]
40. Knowledge About Cervical Cancer Risk Factors and Practices of Pap Testing Among Turkish Immigrant Women in the United States.
Uysal Toraman A; Yildirim N
J Immigr Minor Health; 2018 Oct; 20(5):1222-1229. PubMed ID: 28929252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]